Mersana Therapeutics, Inc. Made Headway
Tue, Apr 07, 2020 at 05:30 PM
Mersana Therapeutics, Inc. (MRSN:NASDAQ) soared at $7.74, a gain of 43.9%. On Mon 06 Apr 20, MRSN:NASDAQ touched a New 2-Week Intraday Low of $5.18. The stock appeared on our News Catalysts scanner on Mon 30 Mar 20 at 07:24 PM in the 'BIOTECH' category. From Mon 23 Mar 20, the stock recorded 60.00% Up Days and 63.64% Green Days
The share price of the company has been moving sideways in recent weeks.
About Mersana Therapeutics, Inc. (MRSN:NASDAQ)
Mersana Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need.
Top 10 Gainers:
- Youngevity International, Inc. (YGYI:NASDAQ), 275%
- Borr Drilling Limited (BORR:NYSE), 102.53%
- DPW Holdings, Inc. (DPW:NYSEMKT), 92.5%
- Sasol Limited (SSL:NYSE), 59.06%
- AeroCentury Corp. (ACY:NYSEMKT), 48.73%
- Mersana Therapeutics, Inc. (MRSN:NASDAQ), 43.87%
- TPG RE Finance Trust, Inc. (TRTX:NYSE), 43.66%
- BioLineRx Ltd. (BLRX:NASDAQ), 41.86%
- Top Ships Inc. (TOPS:NASDAQ), 38.63%
- Party City Holdco Inc. (PRTY:NYSE), 37.56%